Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Sarcoma 3Neoplasms 3Brain Neoplasms 3Thyroid Carcinoma, Anaplastic 2Sarcoma, Synovial 2Prostatic Neoplasms 2Neurofibrosarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Gliosarcoma 2Glioblastoma 2Dermatofibrosarcoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2Zollinger-Ellison Syndrome 1Wilms Tumor 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Thyroid Neoplasms 1Somatostatinoma 1Solid Neoplasm 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Recurrent Uterine Corpus Sarcoma 1Recurrent Lymphoepithelioma of the Nasopharynx 1Pheochromocytoma 1Perivascular Epithelioid Cell Neoplasms 1Paraganglioma, Extra-Adrenal 1Paraganglioma 1Ovarian Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 9Specimen Handling 4Iodine-131 4Trastuzumab 3Thyrotropin Alfa 3Sorafenib 3Nivolumab 3Fluorodeoxyglucose F18 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3trametinib 2tipifarnib 2romidepsin 2omipalisib 2dabrafenib 2cabozantinib 2aldesleukin 2Triiodothyronine 2Sunitinib 2Ipilimumab 2Iodine-124 2CTLA-4 Antigen 2Bortezomib 2Biopsy 2vandetanib 1ulixertinib 1trastuzumab biosimilar HLX02 1tanespimycin 1sargramostim 1sapanisertib 1relatlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Thyroid Neoplasms × pazopanib × Clear all
NCT00625846 2020-02-26

Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer

National Cancer Institute (NCI)

Phase 2 Completed
152 enrolled 16 charts
EndocrineHead & Neck

Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡